Journey101 Home PageArticles

HomeSite MapMail



By Imogen Evans, Hazel Thornton, and Iain Chalmers


91 Angell M. Is academic medicine for sale? New England Journal of Medicine

92 Grant J, Green L, Mason B. From bench to bedside: Comroe and Dripps revisited.
HERG Research Report No. 30. Uxbridge, Middlesex: Brunel University Health
Economics Research Group, 2003.

93 Pound P, Ebrahim S, Sandercock P, et al. Reviewing Animal Trials Systematically
(RATS) Group. Where is the evidence that animal research benefits humans? British
Medical Journal 2004;328:514–7.

94 Jones S. Genetics in medicine: real promises, unreal expectations [Milbank report]. New York: Milbank Memorial Fund, 2000. Available from: [accessed 12 December 2005].

95 Mackillop WJ, Palmer MJ, O’Sullivan B, et al. Clinical trials in cancer: the role of
surrogate patients in defining what constitutes an ethically acceptable clinical
experiment. British Journal of Cancer 1989;59:388–95.

96 Jobling R. Therapeutic research into psoriasis: patients’ perspectives, priorities and
interests. In: Rawlins M, Littlejohns P, ed. Delivering quality in the NHS 2005.
Abingdon: Radcliffe Publishing Ltd, pp53–6.

97 Dixon-Woods M. Agarwak S, Jones J, et al. Synthesising qualitative and quantitative
evidence: a review of possible methods. Journal of Health Services Research and Policy

98 Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke: consumer
involvement in design of new randomised controlled trial. British Medical Journal

99 Donovan J, Mills N, Smith M, et al. Quality improvement report: improving design
and conduct of randomised trials by embedding them in qualitative research:
ProtecT (prostate testing for cancer and treatment) study. British Medical Journal

100 Edwards A, Elwyn G, Atwell C, et al. Shared decision making and risk communication in general practice – a study incorporating systematic literature reviews, psychometric evaluation of outcome measures, and quantitative, qualitative and health economic analyses of a cluster randomised trial of professional skill development. Report to ‘Health in Partnership’ programme, UK Department of Health. Cardiff: Department of General Practice, University of Wales College of Medicine, 2002.

101 Longo M, Cohen D, Hood K, et al. Involving patients in primary care consultations:
assessing preferences using Discrete Choice Experiments. British Journal of General Practice 2006;56:35–42.

102 Marsden J, Bradburn J. Patient and clinician collaboration in the design of a national randomised breast cancer trial. Health Expectations 2004;7:6–17.

103 Warlow C, Sandercock P, Dennis M, Wardlaw J. Research funding. Lancet 1999;353:1626.

104 Chalmers I, Rounding C, Lock K. Descriptive survey of non-commercial randomised
trials in the United Kingdom, 1980–2002. British Medical Journal 2003;327:1017–9.

105 Relman AS. Publications and promotions for the clinical investigator. Clinical
Pharmacology and Therapeutics 1979;25:673–6.

106 Warlow C. Building trial capacity (in a hostile environment). Paper presented at
Clinical Excellence 2004, Birmingham, 30 November 2004.

107 Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345: 1455–63.

108 Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. The Cochrane
Database of Systematic Reviews 2005, Issue 1. Art. No.: CD000196. Available from: [accessed 3 January 2006].

109 Roberts I, Yates D, Sandercock P, et al; CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004;364:1321–8.

110 House of Commons Health Committee. The influence of the pharmaceutical industry. Fourth Report of Session 2004–2005. London: Stationery Office, 2005. Available from: cmhealth/42/42.pdf [accessed 1 January 2006].

111 MRC announces plans for strengthening UK clinical research. MRC Network,
Summer 2005.

112 Department of Health. Best research for best health: a new national health research
strategy. London: Stationery Office, 2006. Available from

113 Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. British Medical Journal 1998;317:235–40.

114 Finfer S, Bellomo R, Bryce N, et al (SAFE Study Investigators). A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine 2004;350:2247–56.

115 Tallon D, Chard J, Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000;355:2037–40.

Designed and Powered by